NPPA fixes retail price of 29 formulations, details
New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India, has fixed the retail price of 29 formulations including those used to treat high blood pressure, type 2 diabetes, certain types of inflammation associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, muscle pain, bone pain, and joint pain, also dietary supplements and antacids.
This came in line with the decision of the 117th authority meeting dated 13.10.2023.
This includes Akums Drugs/Mankind Pharma's Cilnidipine and Telmisartan Tablets, Synokem Pharmaceuticals/ Cipla's Montelukast and Fexofenadine Hydrochloride Suspension, Exemed Pharmaceuticals /Eris Lifesciences's Linagliptin plus Metformin Hydrochloride (ER) Tablet, Akums Drugs / Zuventus Healthcare's Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet, Alkem Health Science's Linagliptin plus Metformin Hydrochloride (ER) Tablet and others.
This came in the exercise of the powers conferred by paragraphs 5, 11, and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May 2013 and S. O. 5249(E) dated 11th November 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (NPPA), has fixed, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer and marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
1 | Paracetamol, Phenylephrine Hydrochloride, Caffeine & Diphenhydramine ne Hydrochloride Tablets | Each uncoated tablet contains: Paracetamol IP 500mg Phenylephrine Hydrochloride IP 5mg Caffeine (Anhydrous) IP 30mg Diphenhydramine Hydrochloride IP 25mg | 1 Tablet | M/s Prosperity Drugs Pvt. Ltd. / M/s Torrent Pharmaceuticals Limited | 3.85 |
2 | Cilnidipine and Telmisartan Tablets | Each film-coated tablet contains: Cilnidipine IP 20mg Telmisartan IP 40mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Mankind Pharma Ltd. | 14.15 |
3 | Ibuprofen Solution for Infusion 400mg/100ml | Each 100ml contains: Ibuprofen IP 400mg Water for injection IP q. s. | 1 ML | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Neon Laboratories Limited | 2.63 |
4 | Phenylephrine Hydrochloride and Chlorpheniramine Maleate Drops IP | Each ml contains: Phenylephrine Hydrochloride IP 5mg Chlorpheniramine Maleate IP 2mg | 1 ML | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Apex Laboratories Pvt. Ltd. | 4.28 |
5 | Ofloxacin and Dexamethasone Eye / Ear Drops | Each ml contains: Ofloxacin IP 0.3% w/v Dexamethasone Sodium Phosphate IP eq. to | 1 ML | M/s Axa Parenterals Ltd. / M/s Intas Pharmaceuticals | 6.00 |
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
Dexamethasone Phosphate 0.1% w/v Benzalkonium Chloride Solution IP 0.02% (As preservative) | Ltd. | ||||
6 | Montelukast and Fexofenadine Hydrochloride suspension | Each 5ml contains: Montelukast Sodium IP eq. to Montelukast 4mg Fexofenadine Hydrochloride IP 60mg | 1 ML | M/s Synokem Pharmaceuticals Ltd. / M/s Cipla Ltd. | 1.79 |
7 | Linagliptin + Metformin Hydrochloride (ER) Tablet | Each film-coated bilayer tablet contains: Linagliptin 2.5mg Metformin Hydrochloride (as Extended release) IP 1000mg | 1 Tablet | M/s Exemed Pharmaceuticals / M/s ERIS Lifesciences Limited | 9.60 |
8 | Calcium, Magnesium, Vitamin D3 & Zinc Tablets | Each uncoated tablet contains: Calcium Citrate USP 1000mg Vitamin D3 IP 200IU Magnesium Hydroxide IP eq. to elemental magnesium 100mg Zinc Sulphate Monohydrate IP eq. to elemental Zinc 4mg | 1 Tablet | M/s Hanuchem Laboratories / M/s Mankind Pharma Ltd. | 9.64 |
9 | Mefenamic Acid + Paracetamol Suspension | Each 5ml contains: Mefenamic Acid IP 50mg Paracetamol IP 125mg | 1 ML | M/s Innova Captab Limited / M/s Macleods Pharmaceuticals Limited | 0.68 |
10 | Mefenamic Acid+ Paracetamol Suspension | Each 5ml contains: Mefenamic Acid IP 100mg Paracetamol IP 250mg | 1 ML | M/s Innova Captab Limited / M/s Macleods Pharmaceuticals Limited | 0.82 |
11 | Calcium, Vitamin D3 & Vitamin B12 Tablets | Each film-coated tablet contains: Calcium Carbonate 1250mg from an organic source (Oyster shell) eq. to Elemental Calcium 500mg Vitamin D3 IP 500 IU Vitamin B12 IP 15mcg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Cipla Ltd. | 8.58 |
12 | Atorvastatin, Clopidogrel and Aspirin Capsules | Each hard gelatin capsule contains: Atorvastatin Calcium IP eq. to Atorvastatin 40mg (As two film-coated tablets) Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg, Aspirin IP 75mg (As a Gastro-resistant tablet) | 1 Capsule | M/s Safetab Life Science / M/s Lupin Limited | 13.22 |
13 | Ferrous | Each film-coated tablet | 1 Tablet | Pure and Cure | 10.37 |
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
Ascorbate, Folic Acid, Zinc & Cyanocobalamin Tablets | contains: Ferrous Ascorbate IP eq. to Elemental Iron 100mg Folic Acid IP 1.5mg Zinc Sulphate Monohydrate IP eq. to Elemental Zinc 22.5mg Cyanocobalamin IP 15mcg | Healthcare Pvt. Ltd. / M/s Cipla Ltd. | |||
14 | Methylcobalami n, Nicotinamide, Pyridoxine Hydrochloride & D-panthenol Injection | Each 2ml contains: Methylcobalamin IP 1000mcg, Nicotinamide 100mg, Pyridoxine Hydrochloride IP 100mg, D-panthenol IP 50mg Benzyl Alcohol IP 2% v/v (As preservative) | Per vial of 2ml | M/s Fast Pharma Pvt. Ltd. / M/s German Remedies Pharmaceuticals Pvt. Ltd. | 66.50 |
15 | Atorvastatin & Ezetimibe Tablets | Each film coated tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin 40mg Ezetimibe IP 10mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Emcure Pharmaceuticals Limited | 32.61 |
16 | Glycopyrronium + Formoterol Fumarate + Budesonide powder for Inhalation | Each capsule contains: Formoterol Fumarate Dihydrate IP eq. to Formoterol Fumarate 12mcg Glycopyrrolate IP eq. to Glycopyrronium 25mcg Budesonide IP 400mcg | 1 Capsule | M/s Penta Kraft / M/s Mankind Pharma Ltd. | 12.98 |
17 | Omeprazole & Domperidone Capsules IP | Each hard gelatin capsule contains: Omeprazole IP 20mg (As enteric coated pellets) Domperidone IP 10mg (As coated pellets) | 1 Capsule | M/s Prochem Pharmaceuticals Pvt. Ltd. / M/s German Remedies Pharmaceuticals Pvt. Ltd. | 6.14 |
18 | Nimesulide& Paracetamol tablet | Each uncoated tablet contains: Nimesulide BP 100mg Paracetamol IP 325mg | 1 Tablet | M/s Lucent Biotech Limited / M/s Torrent Pharmaceuticals Ltd. | 3.91 |
19 | Sitagliptin Phosphate & Metformin Hydrochloride Tablet | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP 64.25mg eq. to Sitagliptin 50mg Metformin Hydrochloride IP 500mg | 1 Tablet | M/s Windlas Biotech Limited | 9.16 |
20 | Sitagliptin Phosphate & Metformin Hydrochloride Tablet | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP 64.25mg eq. to Sitagliptin 50mg | 1 Tablet | M/s Windlas Biotech Limited | 10.37 |
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
Metformin Hydrochloride IP 1000mg | |||||
21 | Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet | Each film coated Bilayered Tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP 1000mg (Sustained Release Form) | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Zuventus Healthcare Limited | 17.16 |
22 | Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet | Each film coated Bilayered Tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP 500mg (Sustained Release Form) | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Zuventus Healthcare Limited | 16.09 |
23 | Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet | Each film coated Bilayered Tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP 1000mg (Sustained Release Form) | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Primus Remedies Pvt. Ltd. | 17.16 |
24 | Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet | Each film coated Bilayered Tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP 500mg (Sustained Release Form) | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Primus Remedies Pvt. Ltd. | 16.09 |
25 | Linagliptin + Metformin Hydrochloride (ER) Tablet | Each film bilayer coated tablet contains: Linagliptin 5mg Metformin Hydrochloride (as Extended release) IP 1000mg | 1 Tablet | M/s Exemed Pharmaceuticals / M/s ERIS Lifesciences Limited | 14.37 |
26 | Linagliptin + Metformin Hydrochloride (ER) Tablet | Each film coated Bilayered tablet contains: Linagliptin 5mg Metformin IP 1000mg Hydrochloride (as Extended | 1 Tablet | M/s Alkem Health Science (A unit of Alkem Laboratories Ltd.) / M/s Alkem | 14.37 |
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
release) | Laboratories Ltd. | ||||
27 | Linagliptin + Metformin Hydrochloride (ER) Tablet | Each film coated Bilayered tablet contains: Linagliptin 5mg Metformin Hydrochloride IP 500mg (as Extended release) | 1 Tablet | M/s Alkem Health Science (A unit of Alkem Laboratories Ltd.) / M/s Alkem Laboratories Ltd. | 12.92 |
28 | Dapagliflozin, Sitagliptin and Metformin Hydrochloride Tablets | Each film coated tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 5mg Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Eris Lifesciences Limited | 14.62 |
29 | Dapagliflozin, Sitagliptin and Metformin Hydrochloride Tablets | Each film coated tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 5mg Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 500mg | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Eris Lifesciences Limited | 13.55 |
The notification further added;
(f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.
(g) Consequent to the fixation of the retail price of such formulation as specified in column (2) of the above table with the strength and name of Manufacturer and marketing Companies specified in the corresponding entries in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that Manufacturer & Marketing Companies as specified in corresponding entries in Columns (2), (3) and (5) thereof, if any, issued prior to this notification, stand(s) superseded.
To view the notice, click the link below:
https://medicaldialogues.in/pdf_upload/retail-engl-224064.pdf
Also Read: NPPA fixes retail prices of 44 formulations
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.